| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |